Here, we present that conolidine, a all-natural analgesic alkaloid used in traditional Chinese medication, targets ACKR3, therefore furnishing added proof of a correlation among ACKR3 and suffering modulation and opening alternate therapeutic avenues to the therapy of Persistent suffering. Ca